Medical software Inhalytix®+

laboratoryparticle sizetest

Overview
Inhalytix®+ is an APSD (Aerodynamic Particle Size Distribution) data analysis software platform that centralises the entire APSD workflow into a single connected environment. It integrates methods, results, user data and equipment records and provides built-in equipment connectivity so compatible instruments can transfer test parameters and operational data directly into the system for faster, more accurate and fully traceable workflows.

Key capabilities

• Direct equipment connectivity for automated data transfer from compatible Copley instruments
• Centralised APSD workflow from method setup to report generation
• Integrated metadata, test parameters and equipment records linked to each result
• Improved lab efficiency and reduced potential for human transcription error
• Support for GMP and 21 CFR Part 11 style compliance features and full audit trails
• Scalable architecture designed for future integration

Product highlights

• Unified APSD workflow: method setup, equipment connectivity, test execution and results reporting in a single platform
• Instant, reliable results: automated data transfer and advanced algorithms deliver fast, accurate metric calculations
• Built-in data integrity controls: integrated validation, structured compliance features and audit trails
• Full traceability: test results automatically linked to method, instrument configuration and operator

Dashboard and user environment
The dashboard provides real-time insight into laboratory activity: active analysts and supervisors, tests prepared/executed/completed, equipment and report configurations. An integrated equipment inventory centralises asset details and links assets to test data and reports. Impactor-specific mensuration data is available for accurate stage cut-off calculations.

Data analysis and reporting
The platform processes imported or entered raw data with advanced algorithms. Results are presented in multiple formats including a Results Summary (key metrics), Group Results (drug fractions), graphical views (log-probit plots, drug deposition, cumulative distribution charts) and support for comparison of up to three test runs. Both standard and custom reports can be generated.

Subscription model & included services
Inhalytix®+ is offered as an all-inclusive subscription. The subscription package includes:

• Unlimited test run analyses
• Continuous software updates to maintain compliance and add features
• Built-in audit trails for traceability
• Customisable methods and reporting capabilities
• Comprehensive technical support
• Optional user training packages

Regulatory alignment
Designed to meet requirements of major international pharmacopoeias and regulatory authorities (Ph. Eur., EMA, USP, FDA, JP, CFDA, ChP). Built-in controls, audit trails and structured approvals support regulated environments.

Additional notes
Inhalytix®+ supports linking HPLC results to originating methods, tracking equipment usage and capturing full audit trails of user activity to ensure accuracy, efficiency and compliance.

Technical specifications

• Product type: APSD data analysis software (desktop / server-based subscription platform)
• Commercial name / model: Inhalytix®+
• Connectivity: Direct integration with compatible Copley instruments for automated parameter and data transfer
• Compliance features: Audit trails, structured approvals and controls to support GMP / regulatory readiness (21 CFR Part 11 style capabilities)
• Reporting: Standard and custom report generation; graphical outputs including log-probit and cumulative distribution plots; up to 3-run comparison
• Subscription includes: unlimited analyses, updates, support, optional training
• Scalability: Designed for future integrations and scalable deployments
• Legacy note: a new version (2.4.0) of the legacy Inhalytix software product has been released (legacy product separate from Inhalytix®+)